Market revenue in 2023 | USD 13.1 million |
Market revenue in 2030 | USD 17.0 million |
Growth rate | 3.8% (CAGR from 2023 to 2030) |
Largest segment | Cardiopulmonary perfusion system |
Fastest growing segment | Cardiopulmonary Perfusion System |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System |
Key market players worldwide | Getinge AB ADR, Medtronic PLC, LivaNova PLC, Terumo Corp, Nipro Corp, Fresenius Medical Care AG, Repligen Corp, Spectrum Brands Holdings Inc, Merck KGaA, Xvivo Perfusion AB |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to perfusion systems market will help companies and investors design strategic landscapes.
Cardiopulmonary perfusion system was the largest segment with a revenue share of 45.8% in 2023. Horizon Databook has segmented the Saudi Arabia perfusion systems market based on cardiopulmonary perfusion system, cell perfusion system, ex-vivo organ perfusion system covering the revenue growth of each sub-segment from 2018 to 2030.
Rising government initiatives and investments, such as Saudi Arabia’s Vision 2030 initiative for the kingdom’s socioeconomic transformation, with healthcare infrastructure development as a pivotal pillar, can help market growth in the coming years.
The plan includes substantial investments to enhance healthcare services across the country, including establishing new hospitals & healthcare facilities, installing new equipment in underserved regions, and expanding & modernizing existing facilities.
As part of this modernization effort, there is a strong emphasis on adopting advanced medical technologies, such as perfusion systems, critical for complex surgeries and organ transplantation procedures. By investing in state-of-the-art healthcare infrastructure and technologies, Saudi Arabia aims to improve the quality of healthcare services, enhance patient outcomes, and position itself as a regional leader in healthcare innovation and delivery.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia perfusion systems market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia perfusion systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account